Similar articles for PMID: 23087184

Year	Number of Results
1991	1
1993	1
1996	1
1998	1
2003	4
2005	1
2006	6
2007	2
2008	2
2009	1
2010	1
2011	1
2012	5
2013	6
2014	2
2015	3
2016	1
2017	3
2018	1
2020	2
2021	1
2024	0

1

Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings.

Thorlund K, Druyts E, Aviña-Zubieta JA, Wu P, Mills EJ. Thorlund K, et al. Ann Rheum Dis. 2013 Sep 1;72(9):1524-35. doi: 10.1136/annrheumdis-2012-201574. Epub 2012 Oct 20. Ann Rheum Dis. 2013. PMID: 23087184

2

Remission in rheumatoid arthritis: wishful thinking or clinical reality?

Sesin CA, Bingham CO 3rd. Sesin CA, et al. Semin Arthritis Rheum. 2005 Dec;35(3):185-96. doi: 10.1016/j.semarthrit.2005.06.003. Semin Arthritis Rheum. 2005. PMID: 16325659

3

Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis.

Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE. Desai RJ, et al. Ann Pharmacother. 2012 Nov;46(11):1491-505. doi: 10.1345/aph.1R203. Epub 2012 Oct 23. Ann Pharmacother. 2012. PMID: 23092868 Review.

4

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.

Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA; RADIUS Investigators. Weaver AL, et al. Curr Med Res Opin. 2006 Jan;22(1):185-98. doi: 10.1185/030079905X65510. Curr Med Res Opin. 2006. PMID: 16393444

5

A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.

American College of Rheumatology Committee to Reevaluate Improvement Criteria. American College of Rheumatology Committee to Reevaluate Improvement Criteria. Arthritis Rheum. 2007 Mar 15;57(2):193-202. doi: 10.1002/art.22552. Arthritis Rheum. 2007. PMID: 17330293 Free article.

6

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J. Zink A, et al. Arthritis Rheum. 2006 Nov;54(11):3399-407. doi: 10.1002/art.22193. Arthritis Rheum. 2006. PMID: 17075823 Free article.

7

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.

Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D. Connock M, et al. Health Technol Assess. 2010 Oct;14(Suppl. 2):1-10. doi: 10.3310/hta14suppl2/01. Health Technol Assess. 2010. PMID: 21047485 Free article. Review.

8

Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.

Chung CP, Thompson JL, Koch GG, Amara I, Strand V, Pincus T. Chung CP, et al. Ann Rheum Dis. 2006 Dec;65(12):1602-7. doi: 10.1136/ard.2005.048975. Epub 2006 Feb 27. Ann Rheum Dis. 2006. PMID: 16504992 Free PMC article. Review.

9

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Furst DE, et al. J Rheumatol. 2003 Dec;30(12):2563-71. J Rheumatol. 2003. PMID: 14719195 Clinical Trial.

10

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Rheumatology (Oxford). 2006 Dec;45(12):1558-65. doi: 10.1093/rheumatology/kel149. Epub 2006 May 16. Rheumatology (Oxford). 2006. PMID: 16705046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year